AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2016
Jul 21, 2016
30718_dirs_2016-07-21_eb2eec5c-3453-4c7a-af6c-3a7ad17b2c57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-07-20
Reporting Person: LUCAS ROGER C (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-20 | Common Stock | S | 100.00 | $111.03 | Disposed | 3615.00 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $91.78 | 2024-10-30 | Common Stock (4000.00) | 4000.00 | Direct |
| Stock Options (Right to Buy) | $87.39 | 2023-10-30 | Common Stock (4000.00) | 4000.00 | Direct |
| Stock Options (Right to Buy) | $87.34 | 2025-10-28 | Common Stock (4260.00) | 4260.00 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2016.
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4